Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 7Unknown 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Carcinoma, Basal Cell 2Recurrence 1Eyelid Neoplasms 1Carcinoma, Squamous Cell 1Adenocarcinoma, Sebaceous 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Mohs Surgery × Clear all
NCT05072327 2021-10-08

Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.

Sun Yat-sen University

Phase NA Unknown
120 enrolled
Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Eyelid Neoplasms, Adenocarcinoma, Sebaceous

NCT00639652 2008-03-20

Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970

University Hospital Tuebingen

Unknown
800 enrolled
Dermatologic

Carcinoma, Basal Cell, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡